anonymous
Guest
anonymous
Guest
And thanks for pointing out another of your failures in BD, when you state " ....Amgen is STILL viewed as a supportive care, growth factor company".Well seeing how our current best selling drug came from BD perhaps you should jump back in the lab and try discovering something that’s not mediocre. Heck most of our therapeutic onc drugs are from BD and not R&D. Vectibix, Blin, Imlygic, Kyprolis...all BD. Back to your hole and discover something...how late to the checkpoint inhibitor space are we going to be? Perhaps you are why Amgen is STILL viewed as a supportive care, growth factor company.
Since I don't work for Amgen, this is your BD malfunction once again. Do something useful for once in your life.